Home > Cashflow Statement > GENNEX LABORATORIES

GENNEX LABORATORIES
Cashflow Statement

GENNEX LABORATORIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

GENNEX LABORATORIES Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹21 Cr₹16 Cr₹6.37 Cr₹5.28 Cr₹5.06 Cr
Adjustment ₹-3.97 Cr₹1.65 Cr₹-0.39 Cr₹2.57 Cr₹1.57 Cr
Changes In working Capital ₹-25 Cr₹-65 Cr₹18 Cr₹5.18 Cr₹-6.54 Cr
Cash Flow after changes in Working Capital ₹-7.58 Cr₹-47 Cr₹24 Cr₹13 Cr₹0.10 Cr
Cash Flow from Operating Activities ₹-11 Cr₹-47 Cr₹24 Cr₹12 Cr₹-1.44 Cr
Cash Flow from Investing Activities ₹0.82 Cr₹19 Cr₹-38 Cr₹-2.47 Cr₹-0.02 Cr
Cash Flow from Financing Activities ₹4.57 Cr₹74 Cr₹21 Cr₹-1.83 Cr₹1.62 Cr
Net Cash Inflow / Outflow ₹-5.41 Cr₹46 Cr₹6.38 Cr₹7.61 Cr₹0.16 Cr
Opening Cash & Cash Equivalents ₹61 Cr₹15 Cr₹8.68 Cr₹1.07 Cr₹0.91 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹56 Cr₹61 Cr₹15 Cr₹8.68 Cr₹1.07 Cr

Compare Cashflow Statement of peers of GENNEX LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENNEX LABORATORIES ₹297.6 Cr -0.4% -10% -11.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,991.0 Cr 0.1% -3.2% -2.6% Stock Analytics
DIVIS LABORATORIES ₹162,371.0 Cr -1.5% -7.3% 2.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,229.0 Cr -1.3% -0.7% 24.4% Stock Analytics
CIPLA ₹108,441.0 Cr 1.5% -8.1% -6.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,407.0 Cr 3.2% 5.6% 3.1% Stock Analytics


GENNEX LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GENNEX LABORATORIES

-0.4%

-10%

-11.6%

SENSEX

2.9%

-1.1%

8.5%


You may also like the below Video Courses